C. Yasasever Et Al. , "Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma," ECCO European Cancer Congress , vol.72, Amsterdam, Netherlands, 2017
Yasasever, C. Et Al. 2017. Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma. ECCO European Cancer Congress , (Amsterdam, Netherlands).
Yasasever, C., Dogru, E., Serilmez, M., Tas, F., & Yasasever, V., (2017). Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma . ECCO European Cancer Congress, Amsterdam, Netherlands
Yasasever, Ceren Et Al. "Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma," ECCO European Cancer Congress, Amsterdam, Netherlands, 2017
Yasasever, Ceren T. Et Al. "Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma." ECCO European Cancer Congress , Amsterdam, Netherlands, 2017
Yasasever, C. Et Al. (2017) . "Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma." ECCO European Cancer Congress , Amsterdam, Netherlands.
@conferencepaper{conferencepaper, author={Ceren TİLGEN YASASEVER Et Al. }, title={Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma}, congress name={ECCO European Cancer Congress}, city={Amsterdam}, country={Netherlands}, year={2017}}